TITLE

Stem Cell -- Tough Sell on Wall Street?

AUTHOR(S)
O'Connell, Brian
PUB. DATE
December 2006
SOURCE
BioPharm International;Dec2006, Vol. 19 Issue 12, p20
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article discusses issues about adult and embryonic stem cells. According to the author, embryonic stem cells are not the cure for Parkinson's disease as there is no scientific evidence which shows the technology to fight the disease effectively. On the other hand, adult stem cells have several research advances which are already being used in human patients wherein 72 maladies for received some benefits.
ACCESSION #
23506703

 

Related Articles

  • Miracle cures and embryonic science.  // Nature Biotechnology;Apr2001, Vol. 19 Issue 4, p287 

    Editorial. Focuses on the U.S. trial in which patients with a severe form of Parkinson's disease received human fetal nerve cell transplants. Side effects of trials; Need for evaluation of stem cell biology and its therapeutic potential before continuation of human testing of stem cells;...

  • Rewiring the Parkinsonian brain. Fricker-Gates, Rosemary A.; Dunnett, Stephen B. // Nature Medicine;Feb2002, Vol. 8 Issue 2, p105 

    Focuses on the clinical application of embryonic stem cells in Parkinson disease (PD). Characteristics of PD; Suggestions made on the role of stem cells as an alternative source of dopamine cells for transplantation in PD patients.

  • Now embryonic stem cells come without the risk of animal diseases. Nowak, Rachel // New Scientist;8/10/2002, Vol. 175 Issue 2355, p16 

    Reports the possibility of growing human embryonic stem cells free of animal diseases. Use of the stem cells to replace the dead nerve cells in patients with Parkinson's disease; Combination of the cells with cells from mouse fetuses and cow serum to grow them; Replacement of mouse cells and...

  • Journal of Clinical Investigation: Generating dopamine via cell therapy for Parkinson's disease.  // Biomedical Market Newsletter;7/19/2012, Vol. 21, p1 

    The article informs that replacement of dopaminergic neurons by neural transplantation with mouse embryonic stem cells is used in treatment of Parkinson's disease.

  • In the news: Promise of therapy. Skipper, Magdalena // Nature Reviews Genetics;Aug2002, Vol. 3 Issue 8, p574 

    Focuses on embryonic stem (ES)-cell research. Potential for therapy; Findings on stem cells in mice and men; Impact of the mouse ES cells on Parkinson's disease.

  • Stem cell bank opens.  // R&D Magazine;Nov2005, Vol. 47 Issue 11, p29 

    This article reports on the opening of the World Stem Cell Hub (WSCH) in South Korea in mid-October 2005. Within 24 hours, WSCH was overwhelmed with 9,500 applications from individuals seeking treatment from incurable diseases. WSCH is the world's first facility to store embryonic stem cells...

  • Rapid Development of Pluripotent Stem Cells as a Potential Therapeutic Modality. Williams, David A. // Molecular Therapy;Jun2009, Vol. 17 Issue 6, p929 

    The author reflects on the development of induced pluripotent stem (iPS) cells as potential tools for therapeutic applications. He discusses the importance of iPS and embryonic stem (ES) cells for biological studies and future therapies. He also examines several researches including the study...

  • Selenite benefits embryonic stem cells therapy in the animal models of Parkinson's disease through inhibiting inflammation. Lipeng Tian; Shi Zhang; Liang Xu; Wen Li; Ying Wang; Wei Chen; Jianqing Ding; Shengdi Chen // Molecular Neurodegeneration;2012 Supplement, Vol. 7, p1 

    An abstract of the article "Selenite Benefits Embryonic Stem Cells Therapy in the Animal Models of Parkinson's Disease Through Inhibiting Inflammation," by Lipeng Tian, Shi Zhang, Liang Xu, Wen Li, Ying Wang, Wei Chen, Jianqing Ding and Shengdi Chen is presented.

  • Therapeutic cloning treats Parkinson's mice.  // New Scientist;3/29/2008, Vol. 197 Issue 2649, p6 

    The article reports that an international team led by Lorenz Studer of the Sloan-Kettering Institute of New York has cured mice with a Parkinson's-like disease, using neurons cloned from their own skin cells. The mice were given a drug to kill neurons that make the neurotransmitter dopamine. The...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics